loader image
Contact Us

Month: October 2026

FDA TAP & RAPID Pathway: What Device Sponsors Need to Know

From FDA TAP to Medicare Coverage: What the RAPID Pathway Could Mean for Breakthrough Device Sponsors For medical device innovators, FDA authorization has never been the only milestone that matters. A device may successfully navigate clinical development and FDA review and…

Read More

FDA Medical Device Cybersecurity Guidance 2026: Sponsor Guide

Cybersecurity is no longer an issue that connected-device manufacturers can address only after product development. For FDA-regulated medical devices, cybersecurity is increasingly part of device safety, quality management, risk management and premarket submission readiness. In February 2026, FDA issued updated final…

Read More

FDA Human Factors Requirements in 2026: What Medical Device Sponsors Should Prepare Before Submission

Why Human Factors Matters in Medical Device Development Human factors is not simply a labeling or documentation exercise. For medical device manufacturers, human factors and usability engineering are fundamental parts of designing a device that intended users can operate safely and…

Read More

FDA eSTAR medical device submission 2026: Why Submission Readiness Starts Earlier

eSTAR in 2026: Why FDA Submission Readiness Must Start Before the Template Is Opened FDA’s electronic Submission Template and Resource, or eSTAR, has changed how many medical device submissions are organized and prepared. But sponsors should be careful not to confuse…

Read More

AI-Enabled Medical Device Clinical Development: FDA PCCP & Lifecycle Planning

Clinical Development for AI-Enabled Medical Devices: Plan for Change Before the Algorithm Changes Traditional medical-device development often assumes that the version evaluated during clinical development will remain relatively stable through authorization and commercial use. AI-enabled medical devices can introduce a different…

Read More

FDA TAP Program in 2026: What Breakthrough Device Sponsors Need to Know

FDA TAP Expansion in 2026: What Breakthrough Device Sponsors Should Know About Clinical Development The FDA’s Total Product Life Cycle Advisory Program (TAP) Pilot has become increasingly relevant for medical device innovators developing technologies intended to address significant unmet clinical needs….

Read More